Previous Post
Tempo Therapeutics Announces First Patient Dosed in Clinical Trial of TT101 For Tissue Repair in Skin Cancer Surgery
Next Post
A Novel Microporous Biomaterial Vaccine Platform for Long-Lasting Antibody Mediated Immunity Against Viral Infection
